Correlation Between Mineralys Therapeutics, and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Century Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Century Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Century Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Century is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Century Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Century Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.63 times more return on investment than Century Therapeutics. However, Mineralys Therapeutics, is 1.63 times more volatile than Century Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Century Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 1,231 in Mineralys Therapeutics, Common on November 1, 2024 and sell it today you would lose (205.00) from holding Mineralys Therapeutics, Common or give up 16.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Century Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Century Therapeutics |
Mineralys Therapeutics, and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Century Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| Mineralys Therapeutics, vs. Griffon | Mineralys Therapeutics, vs. RCI Hospitality Holdings | Mineralys Therapeutics, vs. Summit Materials | Mineralys Therapeutics, vs. EastGroup Properties |
| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |